synthagen laboratories bpc 157 BPC-157 + TB-500 Research Compound

FOXO3: Forkhead Box Class O3

We combine both automated and manual peptide synthesizers with advanced solution and solid-phase synthesis techniques to produce peptides of exceptional qualityconsistently exceeding 99% purity

While not as targeted as injectables, troches can complement topical or microneedling protocols in comprehensive anti-aging or regenerative plans

Fan H, Bhullar KS, Wang Z, Wu J

Resveratrol-mediated SIRT1 activation attenuated tesaglitazar-induced cardiac dysfunction and corrected myocardial mitochondrial respiration in C57BL/6 and diabetic mice but not in cardiomyocyte-specific Sirt1 / mice

Given that combined administration of single PPAR and PPAR agonists prevented rosiglitazone-mediated upregulation of PGC1, and treatment with the dual PPAR/ agonist, tesaglitazar, had an inhibitory effect on cardiac PGC1 levels, we tested whether combined PPAR and PPAR activation affects mitochondrial abundance and function